Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study

EBioMedicine

Volumn 6, Issue , 2016, Pages 231-237

  Koopman, F A ^a   Tang, M W ^a   Vermeij, J ^a   de Hair, M J ^a,b   Choi, I Y ^a   Vervoordeldonk, M J ^a   Gerlag, D M ^a   Karemaker, J M ^c   Tak, P P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autonomic nervous system; Heart rate; Heart rate variability; Norepinephrine; Preclinical; RA

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CORTICOSTEROID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NICOTINIC RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PARASYMPATHETIC NICOTINIC ACETYLCHOLINE RECEPTOR TYPE 7; PROTEIN ANTIBODY; RHEUMATOID FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BUNGAROTOXIN RECEPTOR;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; MALE; MONOCYTE; NORMAL HUMAN; OBSERVATIONAL STUDY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX; SIGNAL TRANSDUCTION; VITAL SIGN; ARTHRITIS, RHEUMATOID; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ARTHRITIS, RHEUMATOID; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84959285780     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.02.029     Document Type: Article

References (40)

1. Adlan A.M., Lip G.Y., Paton J.F., Kitas G.D., Fisher J.P. Autonomic function and rheumatoid arthritis-a systematic review. Semin. Arthritis Rheum. 2014.
2. Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62(9):2569-2581.
3. Anon. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996, 93(5):1043-1065.
4. Antman E.M., Bennett J.S., Daugherty A., Furberg C., Roberts H., Taubert K.A. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007, 115(12):1634-1642.
5. Aydemir M., Yazisiz V., Basarici I., et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 2010, 19(3):255-261.
6. Bhala N., Emberson J., Merhi A., et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013, 382(9894):769-779.
7. Borman P., Gokoglu F., Kocaoglu S., Yorgancioglu Z.R. The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study. Clin. Rheumatol. 2008, 27(10):1267-1273.
8. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405(6785):458-462.
9. Bos W.H., Wolbink G.J., Boers M., et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann. Rheum. Dis. 2010, 69(3):490-494.
10. de Hair M.J., Landewe R.B., van de Sande M.G., et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann. Rheum. Dis. 2013, 72(10):1654-1658.
11. de Hair M.J., van de Sande M.G., Ramwadhdoebe T.H., et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheum. 2014, 66(3):513-522.
12. Evrengul H., Dursunoglu D., Cobankara V., et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 2004, 24(4):198-202.
13. Gerlag D.M., Raza K., van Baarsen L.G., et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann. Rheum. Dis. 2012, 71(5):638-641.
14. Gerlag D.M., Norris J.M., Tak P.P. RA: from risk factors and pathogenesis to prevention: towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment. Rheumatology 2015, Sep 15, pii: kev347 (Epub ahead of print).
15. Golczynska A., Lenders J.W., Goldstein D.S. Glucocorticoid-induced sympathoinhibition in humans. Clin. Pharmacol. Ther. 1995, 58(1):90-98.
16. Goldstein R.S., Bruchfeld A., Yang L., et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 2007, 13(3-4):210-215.
17. Harle P., Straub R.H., Wiest R., et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann. Rheum. Dis. 2006, 65(1):51-56.
18. Hirano D., Nagashima M., Ogawa R., Yoshino S. Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. J. Rheumatol. 2001, 28(3):490-495.
19. Holman A.J., Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton. Neurosci. 2008, 143(1-2):58-67.
20. Igari T., Takeda M., Obara K., Ono S. Catecholamine metabolism in the patients with rheumatoid arthritis. Tohoku J. Exp. Med. 1977, 122(1):9-20.
21. Inoue T., Iseki K., Ohya Y. Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease. Hypertens. Res. 2013, 36(10):838-844.
22. Janse van Rensburg D.C., Ker J.A., Grant C.C., Fletcher L. Effect of exercise on cardiac autonomic function in females with rheumatoid arthritis. Clin. Rheumatol. 2012, 31(8):1155-1162.
23. Klareskog L., Catrina A.I., Paget S. Rheumatoid arthritis. Lancet 2009, 373(9664):659-672.
24. Koopman F.A., Stoof S.P., Straub R.H., Van Maanen M.A., Vervoordeldonk M.J., Tak P.P. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 2011, 17(9-10):937-948.
25. Koopman F.A., Schuurman P.R., Vervoordeldonk M.J., Tak P.P. Vagus nerve stimulation: a new bioelectronics approach to treat rheumatoid arthritis?. Best Pract. Res. Clin. Rheumatol. 2014, 28(4):625-635.
26. Lazzerini P.E., Acampa M., Capecchi P.L., et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur. J. Intern. Med. 2013, 24(4):368-374.
27. Monfredi O., Lyashkov A.E., Johnsen A.B., et al. Biophysical characterization of the underappreciated and important relationship between heart rate variability and heart rate. Hypertension 2014, 64(6):1334-1343.
28. Nesvold A., Fagerland M.W., Davanger S., et al. Increased heart rate variability during nondirective meditation. Eur. J. Prev. Cardiol. 2012, 19(4):773-780.
29. Palm S., Hinrichsen H., Barth J., et al. Modulation of lymphocyte subsets due to psychological stress in patients with rheumatoid arthritis. Eur. J. Clin. Investig. 1992, 22(Suppl. 1):26-29.
30. Prevoo M.L., van 't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38(1):44-48.
31. Rang S., Wolf H., van Montfrans G.A., Karemaker J.M. Serial assessment of cardiovascular control shows early signs of developing pre-eclampsia. J. Hypertens. 2004, 22(2):369-376.
32. Routledge F.S., Campbell T.S., McFetridge-Durdle J.A., Bacon S.L. Improvements in heart rate variability with exercise therapy. Can. J. Cardiol. 2010, 26(6):303-312.
33. Scott D.L., Choy E.H., Greeves A., et al. Standardising joint assessment in rheumatoid arthritis. Clin. Rheumatol. 1996, 15(6):579-582.
34. Sharma P., Makharia G.K., Ahuja V., Dwivedi S.N., Deepak K.K. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Dig. Dis. Sci. 2009, 54(4):853-861.
35. Thayer J.F., Lane R.D. The role of vagal function in the risk for cardiovascular disease and mortality. Biol. Psychol. 2007, 74(2):224-242.
36. Valentini M., Parati G. Variables influencing heart rate. Prog. Cardiovasc. Dis. 2009, 52(1):11-19.
37. Van Maanen M.A., Vervoordeldonk M.J., Tak P.P. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 2009, 5(4):229-232.
38. Vlcek M., Rovensky J., Blazicek P., et al. Sympathetic nervous system response to orthostatic stress in female patients with rheumatoid arthritis. Ann. N. Y. Acad. Sci. 2008, 1148:556-561.
39. Vlcek M., Rovensky J., Eisenhofer G., et al. Autonomic nervous system function in rheumatoid arthritis. Cell. Mol. Neurobiol. 2012, 32(5):897-901.
40. Zhang Y., de Peuter O.R., Kamphuisen P.W., Karemaker J.M. Search for HRV-parameters that detect a sympathetic shift in heart failure patients on beta-blocker treatment. Front. Physiol. 2013, 4:81.